Reply
Chen Xie, Jian‐Hong Fang, Shi‐Mei Zhuang, the other authors – 11 June 2020
Chen Xie, Jian‐Hong Fang, Shi‐Mei Zhuang, the other authors – 11 June 2020
Davide Ghinolfi, Quirino Lai, Daniele Dondossola, Riccardo De Carlis, Marinella Zanierato, Damiano Patrono, Stefano Baroni, Domenico Bassi, Fabio Ferla, Andrea Lauterio, Chiara Lazzeri, Paolo Magistri, Fabio Melandro, Duilio Pagano, Daniele Pezzati, Matteo Ravaioli, Erion Rreka, Luca Toti, Alberto Zanella, Patrizia Burra, Salvatore Petta, Massimo Rossi, Philippe Dutkowski, Wayel Jassem, Paolo Muiesan, Cristiano Quintini, Markus Selzner, Umberto Cillo – 10 June 2020 – The use of machine perfusion (MP) in liver transplantation (LT) is spreading worldwide.
Hilary M. DuBrock, Michael J. Krowka – 9 June 2020
Hilary M. DuBrock, Michael J. Krowka – 9 June 2020
Alessio Gerussi, Cristina Rigamonti, Chiara Elia, Nora Cazzagon, Annarosa Floreani, Roberta Pozzi, Pietro Pozzoni, Ernesto Claar, Luisa Pasulo, Stefano Fagiuoli, Laura Cristoferi, Marco Carbone, Pietro Invernizzi – 9 June 2020 – Chronic immunosuppression is associated with increased and more severe viral infections. However, little is known about the association between immunosuppression and severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection.
Sumera Rizvi, Juan Wang, Anthony B. El‐Khoueiry – 9 June 2020
Florence Wong, Jeroen Capel, Patrick S. Kamath – 9 June 2020
Alessio Gerussi, Cristina Rigamonti, Chiara Elia, Nora Cazzagon, Annarosa Floreani, Roberta Pozzi, Pietro Pozzoni, Ernesto Claar, Luisa Pasulo, Stefano Fagiuoli, Laura Cristoferi, Marco Carbone, Pietro Invernizzi – 9 June 2020 – Chronic immunosuppression is associated with increased and more severe viral infections. However, little is known about the association between immunosuppression and severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection.
Michael Munroe, Evandro Luis Niero, Wilson Chun Fok, Alexandre Teixeira Vessoni, Ho‐Chang Jeong, Kirsten Ann Brenner, Luis Francisco Zirnberger Batista – 9 June 2020
Zhuolun Song, Chong Dong, Xingchu Meng, Chao Sun, Kai Wang, Hong Qin, Chao Han, Yang Yang, Fubo Zhang, Weiping Zheng, Jing Chen, Keran Duan, Bowen Bi, Wei Gao – 8 June 2020 – The goal of this study was to evaluate the efficacy of a perioperative prophylactic strategy against de novo hepatitis B virus (HBV) infection in pediatric liver transplantation (LT) recipients with hepatitis B core antibody (HBcAb)–positive grafts. A total of 482 pediatric recipients transplanted between 2013 and 2017 were enrolled, and 170 recipients received HBcAb‐positive liver grafts.